Home / Performance

Low Testosterone and ED: When One Fix Helps Both

Written by Marcus W.

Published April 24, 2026

# Low Testosterone and ED: When Treating One Fixes the Other

In men with documented *hypogonadism* — clinically low testosterone — correcting the hormonal deficit can meaningfully improve erectile function, sometimes without additional medication.

How These Two Conditions Overlap

Erectile dysfunction (ED) and low testosterone (clinically called hypogonadism) are listed separately in the diagnostic manuals, but they share substantial biological real estate. Roughly 20–40% of men presenting with ED have measurable testosterone deficiency, according to data published in the Journal of Sexual Medicine. That overlap is not coincidental — testosterone is deeply woven into the physiology of erection.

Understanding the connection starts with mechanism.

Mechanism of Action: What Testosterone Does for Erections

An erection depends on a coordinated sequence: sexual arousal triggers the nervous system to release nitric oxide (NO) in penile tissue. NO relaxes the smooth muscle of the corpus cavernosum (the paired cylinders of spongy tissue inside the penis), allowing blood to fill them under pressure.

Testosterone supports this cascade at multiple points:

• It upregulates nitric oxide synthase (the enzyme that produces NO) in penile endothelial cells.
• It maintains the sensitivity of central neural pathways that initiate sexual desire and arousal.
• It preserves the structural integrity of penile smooth muscle; prolonged androgen deficiency can cause fibrosis (scarring) that mechanically impairs erections.

When testosterone falls — particularly total testosterone below 300 ng/dL, a commonly used clinical threshold — the entire chain weakens. Desire drops, NO production declines, and vascular response becomes sluggish. The result can look identical to ED caused by cardiovascular disease or diabetes, which is why a thorough workup matters.

The Evidence Base

Testosterone Replacement and Erectile Function

A 2016 landmark trial — the Testosterone Trials (TTrials), a coordinated set of seven placebo-controlled studies funded by the NIH and published in the New England Journal of Medicine — enrolled 790 men aged 65 and older with symptomatic hypogonadism. The Sexual Function Trial component showed statistically significant improvements in sexual desire and erectile function in men randomized to testosterone gel versus placebo. Results may vary.

A 2023 meta-analysis in the Journal of Clinical Endocrinology and Metabolism synthesizing 49 randomized controlled trials found that testosterone replacement therapy (TRT) improved erectile function scores significantly compared with placebo — with the largest benefit observed in men whose testosterone was genuinely deficient rather than in the low-normal range.

When PDE5 Inhibitors Underperform

Phosphodiesterase type 5 inhibitors (PDE5 inhibitors) — the drug class that includes sildenafil and tadalafil — are first-line therapy for ED. They work by blocking the enzyme that breaks down cyclic GMP, a signaling molecule downstream of nitric oxide, thereby prolonging smooth-muscle relaxation and blood inflow.

In men with normal testosterone, PDE5 inhibitors are highly effective. In men with untreated hypogonadism, response rates are meaningfully lower. A study in the Journal of Clinical Endocrinology and Metabolism found that men with low testosterone who failed sildenafil showed significant improvement after testosterone was corrected — suggesting that androgen deficiency was limiting the upstream NO signal that PDE5 inhibitors depend on. Results may vary.

The clinical implication: if you have ED and your testosterone has never been measured, you may be missing a correctable root cause.

Who Is — and Is NOT — a Candidate for TRT

Potentially appropriate candidates include men with: - Documented low testosterone on at least two morning blood draws (morning levels are highest due to diurnal variation) - Symptoms consistent with hypogonadism: decreased libido, fatigue, reduced muscle mass, depressed mood - No active contraindications

TRT is generally contraindicated or requires careful specialist input in men with: - Active or suspected prostate cancer or breast cancer - Polycythemia (elevated red blood cell count, as TRT can worsen this) - Untreated severe obstructive sleep apnea - Desire for fertility in the near term (TRT suppresses sperm production) - Hematocrit above 54%

The prescribing provider determines whether testosterone therapy is appropriate after a complete medical intake, including lab work.

A Note for Testicular Cancer Awareness Month

April is Testicular Cancer Awareness Month — a timely reminder that good endocrine health starts with knowing what's there. The American Cancer Society recommends that men become familiar with the normal size and texture of their testicles and promptly report any painless lump, swelling, or change in consistency to a physician. A prior history of testicular cancer or orchidectomy (surgical removal) is directly relevant to testosterone status and should be disclosed during any hormone evaluation. Stewardship of reproductive health is part of the same picture.

What to Expect on Treatment

Timeline: Testosterone levels typically normalize within 3–6 weeks of starting TRT. Improvements in libido often appear first, within 3–4 weeks. Erectile function improvement, if it occurs, may take 3–6 months of sustained therapy. Results may vary.

Common side effects to monitor: - Erythrocytosis (elevated red blood cell count) — your provider will monitor hematocrit - Acne or oily skin - Fluid retention - Testicular atrophy (from suppression of the hypothalamic-pituitary-gonadal axis) - Sleep apnea worsening

Contact your provider through the patient portal if you experience: chest pain, shortness of breath, leg swelling, significant mood changes, or any new urinary symptoms. Do not route these questions to support staff.

The Good Guy Rx Pathway

Good Guy Rx is a technology platform that connects men to independent licensed physicians and independent state-licensed pharmacies. If you have concerns about ED, low libido, or unexplained fatigue, the starting point is a structured medical intake — a licensed provider reviews your history, symptoms, and labs, then determines whether a treatment plan that may include testosterone therapy, a PDE5 inhibitor such as sildenafil or tadalafil, or a combination approach is appropriate for you. Begin your ED assessment here.

Sources

• Testosterone Trials (TTrials) — Sexual Function Trial — *New England Journal of Medicine*, 2016
• Testosterone Deficiency and Erectile Dysfunction — *Journal of Clinical Endocrinology and Metabolism*, 2023 meta-analysis
• Testosterone Supplementation in Men with Sildenafil Non-Response — *Journal of Clinical Endocrinology and Metabolism*, 2004
• Prevalence of Hypogonadism in Men with ED — *Journal of Sexual Medicine*
• Testicular Self-Examination — American Cancer Society
• American Urological Association: Evaluation and Management of Testosterone Deficiency Guidelines

This article is educational. A licensed provider determines whether you are a candidate after a medical intake.

Ready to start your journey?

Complete your free online visit and see if GLP-1 treatment is right for you.

Get Started

Related Articles

Tadalafil 10mg vs 20mg: How Providers Choose

Marcus W. · Jun 30, 2026

Dissolvable ED Strips vs Pills: Onset, Discretion, How to Choose

David K. · Jun 24, 2026